Intimation for closure of trading window in terms of SEBI(Prohibition of Insider Trading) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has informed BSE that its trading window for dealing in company securities will be closed starting Tuesday, 1st July 2025. The window will remain shut for all Insiders, Designated Persons and their immediate relatives until 48 hours after the company declares its unaudited standalone financial results for the quarter ending 30th June 2025 (Q1 FY26). During this period, these persons are barred from buying, selling or pledging shares of the company. The date of the board meeting to approve these quarterly results will be announced separately. The intimation has been signed by Managing Director Vishnubhai Mohanbhai Desai.
This is a routine regulatory compliance filing required under SEBI's Insider Trading Regulations and does not indicate any insider activity. Retail investors should expect Q1 FY26 results to be announced in the coming weeks, which could be a near-term catalyst for the stock.